Home

Articles from Mars, Incorporated

Mars to Acquire Kellanova
Mars, Incorporated, a family-owned, global leader in pet care, snacking and food, and Kellanova (NYSEK), a leading company in global snacking, international cereal and noodles, North American plant-based foods and frozen breakfast foods, today announced that they have entered into a definitive agreement under which Mars has agreed to acquire Kellanova for $83.50 per share in cash, for a total consideration of $35.9 billion, including assumed net leverage.1 The transaction price represents a premium of approximately 44% to Kellanova’s unaffected 30-trading day volume weighted average price and a premium of approximately 33% to Kellanova’s unaffected 52-week high as of August 2, 2024. The total consideration represents an acquisition multiple of 16.4x LTM adjusted EBITDA as of June 29, 2024.
By Mars, Incorporated · Via Business Wire · August 14, 2024
Mars, Incorporated Enters Exclusive Discussions to Acquire the Entire Stake in French Veterinary Diagnostics Businesses Cerba Vet and ANTAGENE Held by the Cerba HealthCare Group
Mars, Incorporated today announced that it has entered into exclusive discussions with Cerba HealthCare with a view to acquiring Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE.
By Mars, Incorporated · Via Business Wire · May 3, 2024
Mars Acquires Nutritious Meal Company Kevin’s Natural Foods
Today Mars, Incorporated, a family-owned, global leader in confectionery, food, and pet care products and services, announced that it has signed an agreement to acquire Kevin’s Natural Foods, a high-growth, nutritious meal company, to join its leading brands in the Mars Food & Nutrition segment.
By Mars, Incorporated · Via Business Wire · July 5, 2023
Mars Completes Acquisition of Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions
Mars, Incorporated (“Mars”) today announced the successful completion of Mars’ acquisition of Heska. On April 3, 2023, the companies announced they had entered into a definitive agreement under which Mars agreed to acquire Heska for $120.00 per share. Heska is now part of Mars Petcare’s Science & Diagnostics division, enabling broader coverage across diagnostics and technology, while accelerating R&D and expanding access globally to pet healthcare solutions.
By Mars, Incorporated · Via Business Wire · June 13, 2023